Scholarlink

Background <p>Physical inactivity is a major driver of atherosclerotic cardiovascular disease (ASCVD) globally, with women in transitional regions like the Middle East facing unique challenges. This is the first study in the Middle East to explore the prevalence of physical activity and its association with ASCVD risk factors in young women, as part of a sub-analysis of the ANCHORS study.</p> Methods <p>In this cross-sectional Analysis of 626 women aged 18–50 from the ANCHORS study (2021–2023), participants were categorized as physically active (≥ 150&#xa0;min/week) or inactive based on self-reported exercise. Data on traditional and emerging ASCVD risk factors were collected through questionnaires and physical assessments. Statistical analyses included chi-square, t-tests, and logistic regression, adjusting for age, residence, education, and BMI.</p> Results <p>Only 25.1% of participants met recommended physical activity levels. Inactivity was significantly associated with higher BMI (<i>p</i> &lt; 0.001), postpartum weight retention (<i>p</i> = 0.010), and a history of gestational hypertension (<i>p</i> = 0.001) and diabetes (<i>p</i> = 0.015). No link was found with dyslipidemia or family history of CVD. Surprisingly, active women reported more depressive symptoms (<i>p</i> = 0.042), possibly indicating greater mental health awareness.</p> Conclusions <p>Physical inactivity is widespread among young Middle Eastern women and closely linked to key ASCVD risk factors. These findings highlight an urgent need for culturally tailored physical activity strategies that also consider mental and social health influences.</p> Clinical trials <p>The study is registered with ClinicalTrials.gov, unique identifier number NCT06199869. The study was registered on 09/01/2024.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of physical activity and its association with atherosclerotic cardiovascular risk factors in young women in the middle east: a sub-analysis of the ANCHORS study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月1日

查看全文
  • Osama Alkouri,
  • Nour Ali Alrida,
  • Rahma Musaed Alabkal,
  • Yousef khader,
  • Zainab Albikawi,
  • Anas Ababneh,
  • Alanoud Alobaidly,
  • Omar Qaladi,
  • Abdulhafith Alharbi,
  • Mohamad jarrah,
  • Nader Alotaibi,
  • Ahmad M. Al-Bashaireh,
  • Ayman Hammoudeh,
  • Mohannad E. AbuRuz,
  • Laith Anwar Almustafa,
  • Own Khraisat,
  • Nezam Al-Nsair

摘要

Background

Physical inactivity is a major driver of atherosclerotic cardiovascular disease (ASCVD) globally, with women in transitional regions like the Middle East facing unique challenges. This is the first study in the Middle East to explore the prevalence of physical activity and its association with ASCVD risk factors in young women, as part of a sub-analysis of the ANCHORS study.

Methods

In this cross-sectional Analysis of 626 women aged 18–50 from the ANCHORS study (2021–2023), participants were categorized as physically active (≥ 150 min/week) or inactive based on self-reported exercise. Data on traditional and emerging ASCVD risk factors were collected through questionnaires and physical assessments. Statistical analyses included chi-square, t-tests, and logistic regression, adjusting for age, residence, education, and BMI.

Results

Only 25.1% of participants met recommended physical activity levels. Inactivity was significantly associated with higher BMI (p < 0.001), postpartum weight retention (p = 0.010), and a history of gestational hypertension (p = 0.001) and diabetes (p = 0.015). No link was found with dyslipidemia or family history of CVD. Surprisingly, active women reported more depressive symptoms (p = 0.042), possibly indicating greater mental health awareness.

Conclusions

Physical inactivity is widespread among young Middle Eastern women and closely linked to key ASCVD risk factors. These findings highlight an urgent need for culturally tailored physical activity strategies that also consider mental and social health influences.

Clinical trials

The study is registered with ClinicalTrials.gov, unique identifier number NCT06199869. The study was registered on 09/01/2024.